Gemcitabine and R115777 (Tipifarnib) Combination Therapy for Metastatic Breast Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 16 Dec 2014
At a glance
- Drugs Gemcitabine (Primary) ; Tipifarnib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
- 12 Jun 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.